Joseph Turk has served on the ReWalk Board since April 2022. Mr. Turk has been an Executive Vice President of Fresenius Medical Care North America since 2019, during which he has served as the President of its Renal Therapies group since July 2021 and as the President of its Home and Critical Care Therapies group from February 2019 until July 2021. He held a number of leadership roles, most recently President, at NxStage Medical, Inc. between 2000 to 2019. Prior to NxStage, Mr. Turk also spent time at Boston Scientific and McKinsey and Company. Mr. Turk holds a B.A. from Wabash College and an M.B.A from the Kellogg Graduate School of Management at Northwestern University.